USPTO Examiner PAULS JOHN A - Art Unit 3683

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18808711SYSTEMS AND METHODS FOR CONFIGURING REGIONAL SETTING(S) ON AN ULTRASOUND IMAGING DEVICEAugust 2024March 2026Allow1910NoNo
18785860APPARATUS AND METHOD FOR GENERATING CLINICAL DECISION SUPPORTJuly 2024April 2025Allow910YesNo
18786262CLINICAL DECISION SUPPORT FOR CHRONIC PAIN MANAGEMENTJuly 2024February 2026Allow1910NoNo
18774639METHOD AND APPARATUS FOR ACQUIRING INFORMATIONJuly 2024February 2026Allow1920NoNo
18770955SYSTEMS AND METHODS FOR MANAGING, MONITORING, AND TREATING PATIENT CONDITIONSJuly 2024January 2026Allow1810NoNo
18675316METHOD FOR INPUTTING MEDICAL-IMAGE DIAGNOSTIC REPORT USING THREE-DIMENSIONAL TEXT DATA STRUCTURE AND COMPUTER-READABLE RECORDING MEDIUM ON WHICH PROGRAM FOR PERFORMING SAME IS RECORDEDMay 2024October 2025Abandon1730YesNo
18662023SYSTEMS AND METHODS FOR MANAGING GLYCEMIC VARIABILITYMay 2024September 2025Allow1610NoNo
18649589VIRTUAL HEALTH COACH FOR FACILITATING DYNAMIC DOSAGE TITRATIONApril 2024February 2025Allow910NoNo
18689329RESEARCH DATA DISCOVERY SYSTEM AND METHODMarch 2024January 2026Abandon2210NoNo
18437817CONVERSATIONAL SERVICES FOR ARTIFICIAL INTELLIGENCE HEALTH SUPPORTFebruary 2024December 2024Allow1010NoNo
18423415DETERMINING A REGIMEN TO IMPROVE HEALTH PARAMETER OF AN OBJECTJanuary 2024February 2026Allow2520NoNo
18575764ANOMALY DETECTION BASED ON COMPLETE BLOOD COUNTS USING MACHINE LEARINGDecember 2023March 2026Abandon2701NoNo
18397326INFORMATION PROCESSING DEVICE AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING PROGRAMDecember 2023March 2026Abandon2610NoNo
18397005INFORMATION PROCESSING DEVICE AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM STORING PROGRAMDecember 2023March 2026Abandon2610NoNo
18540572System and Method for Patient Care ImprovementDecember 2023December 2025Allow2410YesNo
18510890CUSTOMIZABLE DATA MANAGEMENT SYSTEMNovember 2023September 2024Allow1010YesNo
18384376SYSTEMS AND METHODS FOR SECURELY STORING PATIENT INFORMATION AND PROVIDING ACCESS THERETOOctober 2023July 2025Allow2120YesNo
18493650IMAGE INTERPRETATION MODEL DEVELOPMENTOctober 2023November 2025Allow2510YesNo
18378122ADAPTIVE CONTROL OF MEDICAL DEVICES BASED ON CLINICIAN INTERACTIONSOctober 2023October 2025Allow2410NoNo
18473018Selecting food ingredients from vector representations of individual proteins using cluster analysis and precision fermentationSeptember 2023November 2025Allow2620YesYes
18238453SYSTEM AND METHOD FOR MEDICAL DISEASE DIAGNOSIS BY ENABLING ARTIFICIAL INTELLIGENCEAugust 2023December 2025Abandon2701NoNo
18449663Control Method, Apparatus, Server, and Storage Medium for a Cryogenic Physical Therapy SystemAugust 2023March 2026Abandon3120NoNo
18336019IMAGE DIAGNOSIS SUPPORT DEVICE, OPERATION METHOD FOR IMAGE DIAGNOSIS SUPPORT DEVICE, AND PROGRAMJune 2023February 2026Abandon3220NoNo
18257265ATLAS-BASED CHARACTERIZATION OF PATENT-SPECIFIC CARDIAC ELECTROMECHANICAL ACTIVATION MAPSJune 2023July 2025Allow2510YesNo
18248684COMPUTERIZED SYSTEM FOR THE REPEATED DETERMINATION OF A SET OF AT LEAST ONE CONTROL PARAMETERS OF A MEDICAL DEVICEApril 2023November 2025Allow3120YesNo
18123025AMPLICON PASSENGERS AS IMMUNE-ONCOLOGY TARGETSMarch 2023August 2025Allow2910NoNo
18114553GRAPHICAL USER INTERFACE WITH INTELLIGENT ICONSFebruary 2023July 2025Abandon2810NoNo
18110629REDUCING NETWORK TRAFFIC ASSOCIATED WITH GENERATING EVENT PREDICTIONS BASED ON COGNITIVE IMAGE ANALYSIS SYSTEMS AND METHODSFebruary 2023April 2025Allow2610YesNo
18166251SYSTEMS AND METHODS FOR PATIENT TARGETED THERAPY DEVELOPMENTFebruary 2023August 2024Allow1810YesNo
18163732PERSONAL, OMIC, AND PHENOTYPE DATA COMMUNITY AGGREGATION PLATFORMFebruary 2023May 2025Abandon2810NoNo
18161589REMOTE MEDICATION DELIVERY SYSTEM AND METHODJanuary 2023February 2026Allow3730NoNo
18007670METHODS FOR PREDICTING TREATMENT RESPONSE IN CANCERSDecember 2022March 2025Allow2810NoNo
18073550METHOD FOR AUTOIMMUNE DISEASE OR SPECIFIC CHRONIC DISEASE RISK EVALUATION, EARLY DETECTION AND TREATMENT SELECTIONDecember 2022May 2025Abandon2910NoNo
18059570AUTOMATED LABELING OF USER SENSOR DATANovember 2022January 2026Allow3730YesNo
17991265METHOD AND TERMINAL DEVICE FOR PROVIDING TOOTH DETERIORATION INFORMATION TO USERNovember 2022February 2026Abandon3930YesNo
17922051CARE-NEEDING PERSON ASSISTANCE SYSTEMOctober 2022December 2025Abandon3721YesNo
17971796SYSTEMS AND METHODS FOR NETWORK-BASED COUNSELINGOctober 2022July 2024Allow2110NoNo
17967959Immunization Management System and MethodOctober 2022December 2025Abandon3860YesNo
17953416Experts Consulted System and Method for Pregnancy, Childbirth and ParentingSeptember 2022September 2025Abandon3620NoNo
17950966ESTIMATING PHARMACOKINETIC PARAMETERS USING DEEP LEARNINGSeptember 2022June 2025Allow3220YesNo
17950913SYSTEM AND METHOD OF LIMITED MOBILITY TRACKINGSeptember 2022February 2025Abandon2910NoNo
17820610MEDICAL INFORMATION PROCESSING DEVICE, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUMAugust 2022February 2026Abandon4240YesNo
17790140SYSTEM FOR PROVIDING GENETIC INFORMATION-BASED PERSONALIZED SOCIAL CONTENT INFORMATION, AND METHOD THEREOFJune 2022February 2025Abandon3210NoNo
17847904MONITORING OF ANOMALIES IN BEHAVIOR TO INCREASE QUALITY OF SOFTWARE DEVELOPMENTJune 2022May 2025Abandon3520YesNo
17844619ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR EXTERNAL ENVIRONMENTSJune 2022November 2025Abandon4110NoNo
17844614ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR INTERIOR ENVIRONMENTSJune 2022February 2025Allow3210YesNo
17844618ATMOSPHERIC MIRRORING AND DYNAMICALLY VARYING THREE-DIMENSIONAL ASSISTANT ADDISON INTERFACE FOR BEHAVIORAL ENVIRONMENTSJune 2022October 2025Abandon4010NoNo
17839536SYSTEM AND METHOD FOR USER ACCEPTANCE TESTJune 2022July 2025Allow3730NoNo
17757119METHOD AND SYSTEM FOR IMPROVING TREATMENT ADHERENCE LEVELJune 2022December 2024Abandon3010NoNo
17782378Systems, Methods, and Media for Automatically Predicting a Classification of Incidental Adrenal Tumors Based on Clinical Variables and Urinary Steroid LevelsJune 2022February 2025Allow3320YesNo
17775568SYSTEMS AND METHODS FOR MEDICAL DEVICE USAGE MANAGMENTMay 2022September 2025Allow4130YesNo
17725918INTERACTION BETWEEN A MASK AND A PATIENT DURING THERAPYApril 2022April 2025Abandon3620NoNo
17657044CUSTOMIZED EXCEPTIONS FOR INTELLIGENT PROTOCOLINGMarch 2022August 2024Allow2910YesNo
17703226CLINICAL DECISION SUPPORT SYSTEM FOR ESTIMATING DRUG-RELATED TREATMENT OPTIMIZATION CONCERNING INFLAMMATORY DISEASESMarch 2022January 2025Abandon3420YesNo
17655917RECYCLING COMPONENTS IN MEDICAL DEVICESMarch 2022August 2024Allow2910YesNo
17697962ARTIFICIAL INTELLIGENCE-BASED DIFFICULT AIRWAY EVALUATION METHOD AND DEVICEMarch 2022March 2025Abandon3620NoNo
17761288APPARATUS, SYSTEM, METHOD, AND COMPUTER READABLE MEDIUM FOR REHABILITATION PLANNING USING MACHINE LEARNINGMarch 2022September 2024Allow3010YesNo
17693151INTELLIGENT SECURE NETWORKED HEALTH MESSAGING SYSTEMS AND METHODSMarch 2022October 2024Abandon3110YesNo
17690117ARTIFICIAL INTELLIGENCE METHODS AND SYSTEMS FOR CONSTITUTIONAL ANALYSIS USING OBJECTIVE FUNCTIONSMarch 2022August 2024Allow2910YesNo
17687150Post-Mortem Multimodal Tumor SupermodelMarch 2022September 2025Allow4220NoNo
17685683MACHINE LEARNING MODELS FOR VEHICLE ACCIDENT POTENTIAL INJURY DETECTIONMarch 2022September 2024Allow3020YesNo
17639797ASSISTIVE SYSTEM USING CRADLEMarch 2022November 2024Abandon3220NoNo
17665847SYSTEM, METHOD, AND GRAPHICAL USER INTERFACE FOR IDENTIFYING MEDICAL CARE PROVIDERS OUTSIDE A PROCESS-OF-CARE STANDARDFebruary 2022June 2024Allow2820NoNo
17569692IDENTIFYING COMMON CARE GAPS BETWEEN PATIENT GROUPSJanuary 2022June 2025Allow4130YesNo
17540459Methods and Systems for Managed Authorization RoutingDecember 2021December 2024Abandon3720NoNo
17596015A METHOD OF EVALUATING AUTOIMMUNE DISEASE RISK AND TREATMENT SELECTIONDecember 2021December 2024Allow3720YesNo
17456626Leveraging Blockchain to Secure Dialysis Components and Maintain Operational LogsNovember 2021June 2024Allow3110NoNo
17517885METHOD FOR PRESENTING THERAPY EVENTS ON A CONTINUOUS TIME-BASED DATA FEEDNovember 2021June 2024Allow3220YesNo
17508322METHODS AND SYSTEMS FOR MICROSATELLITE ANALYSISOctober 2021May 2025Allow4330YesNo
17598998DEVICE AND APPLICATION FOR INTEGRATED MANAGEMENT OF ARTIFICIAL JOINTSSeptember 2021July 2025Abandon4540YesNo
17384455INTERCOMMUNICATION AND COOPERATIVE OPERATION OF SURGICAL DEVICESJuly 2021March 2024Allow3210NoNo
17356699AUTOMATED PLACENTAL MEASUREMENTJune 2021December 2024Abandon4210NoNo
17136964EMERGENCY MANAGEMENT SYSTEMDecember 2020August 2025Allow5640NoNo
17000006EXTRACTING CLINICALLY RELEVANT INFORMATION FROM MEDICAL RECORDSAugust 2020February 2026Abandon6040YesYes
16906021Systems and Methods for Displaying and Updating an Electronic Medical Record for a PatientJune 2020November 2025Abandon6040YesYes
16753504ADDENDUM-BASED REPORT QUALITY SCORECARD GENERATIONApril 2020November 2025Abandon6080NoYes
16739667IDENTIFYING CANCER THERAPIESJanuary 2020March 2025Allow6060YesNo
16507521METHOD AND SYSTEM TO AUTOMATE THE DESIGNATION OF THE INTERNATIONAL CLASSIFICATION OF DISEASE CODES FOR A PATIENTJuly 2019March 2023Allow4580NoNo
16506969PATIENT TRACKING AND DYNAMIC UPDATING OF PATIENT PROFILEJuly 2019August 2024Allow6080YesNo
16463871MEDICAL TOOLS MANAGEMENT SYSTEM AND METHODS FOR OPERATING SAMEMay 2019June 2025Abandon6070NoNo
16412335METHOD OF CERTIFYING A CBD PRODUCTMay 2019August 2025Allow6060NoYes
16403310SYSTEM AND METHOD FOR DETERMINATION AND CONCURRENT DISPLAY OF MEDICAL EXPERT OPINION AND GUIDELINESMay 2019November 2025Abandon6060YesYes
15982992SYSTEM AND METHOD FOR MEDICAL RESOURCE UTILIZATION MANAGEMENTMay 2018March 2019Allow1010NoNo
15887448METHODS AND SYSTEMS FOR COGNITIVE BEHAVIORAL THERAPYFebruary 2018April 2020Allow2600NoNo
15746767SYSTEMS AND METHODS FOR ANALYZING HEALTHCARE DATAJanuary 2018October 2024Abandon6060YesYes
14987947QUALITY VALUE UNIT SYSTEM AND METHODJanuary 2016August 2023Abandon60130NoNo
14810000MOBILE TERMINAL AND CONTROLLING METHOD THEREOFJuly 2015August 2019Allow4821YesNo
14688116NETWORK SYSTEM AND METHOD FOR CONTROLLING A COMPUTER TOMOGRAPHApril 2015July 2018Allow3920NoNo
14560348FACILITATING HEALTH MANAGEMENT OF SUBJECTSDecember 2014April 2020Allow6020NoYes
13374748EVIDENCE-BASED HEALTHCARE INFORMATION MANAGEMENT PROTOCOLSJanuary 2012April 2019Allow6090YesNo
12896275SYSTEM AND METHOD FOR INTEGRATED VERIFICATION AND ASSEMBLY OF MULTI-SCRIPT POUCHES INTO A HOUSING CONTAINEROctober 2010August 2014Allow4620NoNo
12668521LOCALIZATION METHOD FOR MOBILE ROBOTS BASED ON LANDMARKSMay 2010August 2014Allow5630YesNo
12721043HEALTH QUALITY MEASURES SYSTEMS AND METHODSMarch 2010April 2014Allow4920YesNo
12596447APPARATUS AND METHODS FOR RENDERING PERSONAL STORIES TO MEDICAL PATIENTSOctober 2009April 2014Allow5420NoNo
11724227Database networks including advanced replication schemesMarch 2007June 2017Abandon60110YesNo
11473960Multi-user remote health monitoring systemJune 2006February 2010Abandon4450YesYes
10972000INFLUENCING COMMUNICATIONS AMONG A SOCIAL SUPPORT NETWORKOctober 2004February 2010Allow6010NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAULS, JOHN A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
5
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
17.8%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
11
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
11
(100.0%)
Filing Benefit Percentile
9.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PAULS, JOHN A - Prosecution Strategy Guide

Executive Summary

Examiner PAULS, JOHN A works in Art Unit 3683 and has examined 33 patent applications in our dataset. With an allowance rate of 63.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 54 months.

Allowance Patterns

Examiner PAULS, JOHN A's allowance rate of 63.6% places them in the 24% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PAULS, JOHN A receive 4.18 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PAULS, JOHN A is 54 months. This places the examiner in the 3% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a -14.3% benefit to allowance rate for applications examined by PAULS, JOHN A. This interview benefit is in the 2% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 16.0% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 10.5% of cases where such amendments are filed. This entry rate is in the 10% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 19% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 37.5% of appeals filed. This is in the 6% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 83.3% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 3.0% of allowed cases (in the 79% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.